A Transdiagnostic Sleep Health Intervention for Veterans With PTSD

NANot yet recruitingINTERVENTIONAL
Enrollment

182

Participants

Timeline

Start Date

January 5, 2026

Primary Completion Date

January 31, 2029

Study Completion Date

January 31, 2029

Conditions
Stress Disorders, Post-TraumaticSleep Initiation and Maintenance Disorders
Interventions
BEHAVIORAL

TranS-C for PTSD

The Transdiagnostic sleep and circadian intervention (TranS-C), developed by Allison Harvey, Ph.D. and Daniel Buysse, M.D., involves a patient-centered, module-based, flexibly structured approach that tackles numerous sleep disturbances using evidence-based strategies with the goal of improving sleep and related impairments in daytime functioning. It is thus well-suited for tackling sleep disturbances and the associated impairments in social, occupational and overall functioning in veterans with PTSD. The proposed study is a randomized, controlled clinical trial examining the effectiveness of a modified TranS-C intervention for veterans with PTSD. The modified approach, TranS-C for PTSD (TSC-PTSD), elevates the importance of nightmare-focused, apnea-focused, and insomnia-focused modules relative to the standard intervention, incorporates an evidence-based relaxation module, and modifies the nightmare and apnea modules based on strategies used for veterans in the VA healthcare system.

BEHAVIORAL

Sleep Psychoeducation Control

Participants will receive psychoeducation about sleep.

Trial Locations (1)

94121-1563

San Francisco VA Medical Center, San Francisco, CA, San Francisco

All Listed Sponsors
lead

VA Office of Research and Development

FED

NCT06549049 - A Transdiagnostic Sleep Health Intervention for Veterans With PTSD | Biotech Hunter | Biotech Hunter